Tokai Pharmaceuticals
Pharmaceutical company that developed therapies for prostate cancer, focusing on androgen receptor pathway modulation. Merged with Novus Therapeutics in 2017.
Location
Cambridge, Massachusetts, USA
Founded
2004
Investors
1
Categories
biotech, oncology, prostate-cancer, acquired
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Apple Tree Partners | New York, USA | biotech-focused | series-aseries-b+2 | 23 |